BeyondSpring, Inc. (BYSI)
0.7733
-0.35
(-30.96%)
USD |
NASDAQ |
Sep 29, 16:00
0.682
-0.09
(-11.81%)
Pre-Market: 08:32
BeyondSpring Enterprise Value : 24.98M for Sept. 29, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 29, 2026 | 24.98M |
| September 28, 2026 | 39.24M |
| September 25, 2026 | 25.14M |
| September 24, 2026 | 22.99M |
| September 23, 2026 | 23.06M |
| September 22, 2026 | 23.62M |
| September 21, 2026 | 23.61M |
| September 18, 2026 | 24.01M |
| September 17, 2026 | 22.33M |
| September 16, 2026 | 22.33M |
| September 15, 2026 | 24.04M |
| September 14, 2026 | 24.43M |
| September 11, 2026 | 24.60M |
| September 10, 2026 | 24.71M |
| September 09, 2026 | 19.04M |
| September 08, 2026 | 18.69M |
| September 04, 2026 | 18.60M |
| September 03, 2026 | 18.77M |
| September 02, 2026 | 18.31M |
| September 01, 2026 | 17.96M |
| August 31, 2026 | 18.70M |
| August 28, 2026 | 20.54M |
| August 27, 2026 | 19.51M |
| August 26, 2026 | 21.56M |
| August 25, 2026 | 22.80M |
| Date | Value |
|---|---|
| August 24, 2026 | 22.35M |
| August 21, 2026 | 22.79M |
| August 20, 2026 | 22.79M |
| August 19, 2026 | 22.87M |
| August 18, 2026 | 22.71M |
| August 17, 2026 | 22.44M |
| August 14, 2026 | 27.69M |
| August 13, 2026 | 34.15M |
| August 12, 2026 | 23.69M |
| August 11, 2026 | 25.67M |
| August 10, 2026 | 25.49M |
| August 07, 2026 | 28.96M |
| August 06, 2026 | 28.96M |
| August 05, 2026 | 33.31M |
| August 04, 2026 | 33.89M |
| August 03, 2026 | 41.29M |
| July 31, 2026 | 40.47M |
| July 30, 2026 | 39.65M |
| July 29, 2026 | 40.47M |
| July 28, 2026 | 41.91M |
| July 27, 2026 | 41.29M |
| July 24, 2026 | 39.24M |
| July 23, 2026 | 37.59M |
| July 22, 2026 | 39.65M |
| July 21, 2026 | 44.58M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.598B |
| Alnylam Pharmaceuticals, Inc. | 33.66B |
| Anika Therapeutics, Inc. | 253.76M |
| Savara, Inc. | 900.80M |
| Vericel Corp. | 2.010B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.75M |
| Total Expenses (Quarterly) | 0.909M |
| EPS Diluted (Quarterly) | -0.0206 |
| Earnings Yield | -21.19% |
| Normalized Earnings Yield | -21.19 |